Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 11Prostatic Neoplasms 3Postoperative Complications 2Ovarian Neoplasms 2Neoplasms 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Tongue Neoplasms 1Thyroid Nodule 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcopenia 1Renal Colic 1Pregnancy, Ectopic 1Polycystic Ovary Syndrome 1Pneumonia 1Pleural Effusion 1Phlebitis 1Pancreatic Neoplasms 1Ovarian Cysts 1Neuroma 1Myoma 1Metabolic Syndrome 1Mesothelioma 1Margins of Excision 1Glioma 1Glioblastoma 1Gastrointestinal Neoplasms 1Frailty 1Endometrial Neoplasms 1

Interventions

Dexamethasone 5Magnetic Resonance Spectroscopy 4Cyclophosphamide 4Blood Specimen Collection 4Surveys and Questionnaires 3Prednisone 3Melphalan 3Lenalidomide 3Biopsy, Fine-Needle 3fluciclovine F-18 2carfilzomib 2Positron-Emission Tomography 2Mammography 2Injections 2Immunohistochemistry 2Gemcitabine 2Cytarabine 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2weifuchun 1vistusertib 1venetoclax 1technetium 99m 1-(1-(2-(bis(carboxymethyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)-2-((1-(2-(bis(carboxymethyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)methyl)-9,14-dioxo-2,8,13,15-tetraazaoctadecane-7,12,16,18-tetracarboxylic acid) 1ricolinostat 1pomalidomide 1phosphoribosylformylglycinamidine synthetase 1pembrolizumab 1ofatumumab 1obinutuzumab 1lortalamine 1irinotecan sucrosofate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Disease × Ultrasonography × Clear all
NCT05927727 2023-07-03

Benign-Malign Differentiation of Axillary Lymph Nodes: The Role Of Superb Microvascular Imaging

Ankara Education and Research Hospital

Phase NA Completed
102 enrolled

Disease, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡